← Back to Search

Radiopharmaceutical

Research F-18 fluciclovine-PET/CT scan for Prostate Adenocarcinoma (BoneMetPETCT Trial)

N/A
Waitlist Available
Led By Phillip H Kuo, MD, PhD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

BoneMetPETCT Trial Summary

This trial is testing whether a PET scan can accurately detect cancerous lesions in the bone, and whether a biopsy is needed to confirm the diagnosis.

Eligible Conditions
  • Prostate Adenocarcinoma

BoneMetPETCT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biopsy

BoneMetPETCT Trial Design

2Treatment groups
Active Control
Group I: Routine F-18 fluciclovine-PET/CT scanActive Control1 Intervention
This arm will consist of prostate cancer patients who have had an F-18 fluciclovine-PET/CT scan for routine standard of care for biochemical recurrence. These patients would be asked to participate in the study only if there is a need for a standard of care bone biopsy.
Group II: Research F-18 fluciclovine-PET/CT scanActive Control1 Intervention
This arm will consist of prostate cancer patients who would not ordinarily obtain an Axumin-PET scan for routine standard of care but have a need for bone biopsy. This will include patients with metastatic castrate resistant prostate cancer. For example, a patient with known lymph node recurrence of prostate cancer and suspicious finding on a bone scan would be asked to participate in the study and get a F-18 fluciclovine-PET/CT scan prior to the standard of care bone biopsy.

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
514 Previous Clinical Trials
148,256 Total Patients Enrolled
Blue Earth DiagnosticsIndustry Sponsor
38 Previous Clinical Trials
2,972 Total Patients Enrolled
Banner University Medical CenterOTHER
9 Previous Clinical Trials
3,217 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma
2018. "Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03496844.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top